Complexa
is a biopharmaceutical company that develops novel therapeutics for the treatment of fibrosis and inflammatory diseases... Read moreComplexa
is a biopharmaceutical company that develops novel therapeutics for the treatment of fibrosis and inflammatory diseases... Read more
News
Jun 03, 2020
MarketScreener
Complexa: Complexa Completes Patient Enrollment in Phase 2 FIRSTx Trial Evaluating CXA-10 in Focal Segmental Glomerulosclerosis, a Rare and Severe Form of Kidney Disease
Apr 29, 2019
The Business Journals: Philadelphia
Complexa: Berwyn biopharma firm focused on inflammatory diseases raises $11M
Feb 25, 2019
Pharmabiz
Complexa: Complexa begins patient dosing in PRIMEx phase 2 trial of CXA─10 to treat pulmonary arterial hypertension
Sep 26, 2018
BioPortfolio
Complexa: Complexa Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250
Jun 01, 2018
BioPortfolio
Complexa: First Patient Dosed in the Complexa Phase 2 Trial of Lead Candidate CXA10 to Treat a Rare and Severe Form of Kidney Disease Focal Segmental Glomerulosclerosis
May 14, 2018
The Business Journals
Complexa: Berwyn biopharm firm names new CEO
Oct 17, 2017
BioPortfolio
Complexa: Complexa Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 11102017 Prices from USD $250
Aug 08, 2017
BioPortfolio
Complexa: Complexa Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 26072017 Prices from USD $250
Aug 03, 2017
funding smes
Complexa: Complexa raises $62M in Series C
Jul 28, 2017
Global Corporate Venturing
Complexa: Complexa structures $62m series C round
Complexa Competitors
1
2
3
4
5
6
7
8
9
10